Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT00805129
Show Display Options
Rank Status Study
1 Active, not recruiting Everolimus (RAD001) in Metastatic Transitional Cell Carcinoma of the Urothelium
Conditions: Bladder Cancer;   Metastatic Transitional Cell Carcinoma
Intervention: Drug: Everolimus

Indicates status has not been verified in more than two years